AACR: a showcase of scientific studies
Jayhawk scientists convened at the annual meeting of the American Association for Cancer Research (AACR) to present findings from The University of Kansas Cancer Center as part of the many offerings at the Walter E. Washington Convention Center in Washington, D.C., from April 6-10, 2013.
Biomarkers may lead to better ovarian cancer testing
While no single test can reliably detect early stage ovarian cancer, especially in its most deadly form, Andrew K. Godwin, Ph.D., associate director for Translational Research for The University of Kansas Cancer Center, hopes to change current consensus that screenings have little benefit in preventing healthy women from dying of the disease.
Molecular analysis of disease pathways focus of new KU research center
A new $11 million, five-year grant will enable University of Kansas researchers on the Lawrence campus to better understand the molecular basis of diseases such as cancer and neurodegenerative disorders such as Parkinson’s, Alzheimer’s and Huntington’s.